Details of the Drug
General Information of Drug (ID: DMCIJU0)
| Drug Name |
N-Benzyl-4-Sulfamoyl-Benzamide
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
n-benzyl-4-sulfamoyl-benzamide; N-benzyl-4-sulfamoylbenzamide; CHEMBL302715; 107619-27-2; Benzamide, 4-(aminosulfonyl)-N-(phenylmethyl)-; 1g4o; ACMC-20mb2s; AC1L1HYJ; SCHEMBL678390; 4-Sulfamoyl-N-benzylbenzamide; CTK0D6518; BDBM12013; DTXSID80274429; MolPort-004-614-705; ZINC403946; HMS3604F04; AKOS001408419; MCULE-1382374853; DB01748; 4-(AMINOSULFONYL)-N-PHENYLMETHYLBENZAMIDE
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 290.34 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.8 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


